Metabolites
Displaying compounds 14651 - 14675 of 16042 in total
| YMDB ID | Name CAS Number | IUPAC Name | Formula Weight | Structure |
|---|---|---|---|---|
| YMDB13392 | MG(22:1(9Z/0:0)/0:0/0:0) | (2R)-2,3-dihydroxypropyl (9Z)-docos-9-enoate | C25H48O4 412.655 | |
| YMDB00613 | zymosterol intermediate 1b | (2S,5S,7S,11R,14R,15R)-5-hydroxy-2,15-dimethyl-14-[(2R)-6-methylhept-5-en-2-yl]tetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-1(10)-ene-6-carbaldehyde | C28H44O2 412.6478 | |
| YMDB16222 | MG(22:1(13Z)/0:0/0:0) | (2S)-2,3-dihydroxypropyl (13Z)-docos-13-enoate | C25H48O4 412.6462 | |
| YMDB16163 | LysoPC(10:0) | [(2R)-3-(decanoyloxy)-2-hydroxypropoxy][2-(trimethylazaniumyl)ethoxy]phosphinic acid | C18H39NO7P 412.4785 | |
| YMDB13355 | Lyso-PS(10:0/0:0) | 2-azaniumyl-3-{[3-(decanoyloxy)-2-hydroxypropyl phosphono]oxy}propanoate | C16H31NO9P 412.396 | |
| YMDB13364 | Lyso-PS(0:0/10:0) | 2-azaniumyl-3-{[2-(decanoyloxy)-3-hydroxypropyl phosphono]oxy}propanoate | C16H31NO9P 412.396 | |
| YMDB13310 | Lyso-PC(10:0/0:0) | [2-({[3-(decanoyloxy)-2-hydroxypropoxy](-lambda3-oxidanidylidene)oxido-lambda5-phosphanyl}oxy)ethyl]trimethylazanium | C18H38NO7P 411.476 | |
| YMDB00901 | dADP 2793-06-8 | [({[(2R,3S)-5-(6-amino-9H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy]phosphonic acid | C10H15N5O9P2 411.2017 | |
| YMDB00769 | squalene 111-02-4 | (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene | C30H50 410.718 | |
| YMDB00268 | 4,4-Dimethylcholesta-8,14,24-trienol 64284-64-6 | (2S,5S,7R,14R,15R)-2,6,6,15-tetramethyl-14-[(2R)-6-methylhept-5-en-2-yl]tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-1(10),11-dien-5-ol | C29H46O 410.6749 | |
| YMDB00015 | Delta 8,14 -Sterol 74635-33-9 | (2S,5S,6S,7S,14R,15R)-2,6,15-trimethyl-14-[(2R)-6-methyl-5-methylideneheptan-2-yl]tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-1(10),11-dien-5-ol | C29H46O 410.6749 | |
| YMDB13294 | LPA(0:0/16:0) | [2-(hexadecanoyloxy)-3-hydroxypropoxy]phosphonic acid | C19H39O7P 410.4825 | |
| YMDB00259 | LPA(16:0/0:0) | [3-(hexadecanoyloxy)-2-hydroxypropoxy]phosphonic acid | C19H39O7P 410.4825 | |
| YMDB13282 | LPA(16:1(9Z)/0:0) | {3-[(9Z)-hexadec-9-enoyloxy]-2-hydroxypropoxy}phosphonic acid | C19H37O7P 408.472 | |
| YMDB13283 | LPA(16:1(11Z)/0:0) | {3-[(11Z)-hexadec-11-enoyloxy]-2-hydroxypropoxy}phosphonic acid | C19H37O7P 408.472 | |
| YMDB13303 | LPA(0:0/16:1(11Z)) | {2-[(11Z)-hexadec-11-enoyloxy]-3-hydroxypropoxy}phosphonic acid | C19H37O7P 408.472 | |
| YMDB01166 | PA(16:1(9Z)/0:0) | [(2R)-3-[(9Z)-hexadec-9-enoyloxy]-2-hydroxypropoxy]phosphonic acid | C19H37O7P 408.4666 | |
| YMDB00187 | 1-palmitoylglycerone 3-phosphate | [3-(hexadecanoyloxy)-2-oxopropoxy]phosphonic acid | C19H37O7P 408.4666 | |
| YMDB13302 | LPA(0:0/16:1(9Z)) | {2-[(9Z)-hexadec-9-enoyloxy]-3-hydroxypropoxy}phosphonic acid | C19H37O7P 408.4666 | |
| YMDB01640 | Astringin 29884-49-9 | (2S,3R,4S,5S,6R)-2-{3-[(E)-2-(3,4-dihydroxyphenyl)ethenyl]-5-hydroxyphenoxy}-6-(hydroxymethyl)oxane-3,4,5-triol | C20H22O9 406.3833 | |
| YMDB00307 | Uridine 5'-diphosphate 58-98-0 | [({[(2R,3S,4R,5R)-5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy]phosphonic acid | C9H14N2O12P2 404.1612 | |
| YMDB00064 | CDP 63-38-7 | [({[(2R,3S,4R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy]phosphonic acid | C9H15N3O11P2 403.1764 | |
| YMDB00400 | 4-Phosphopantothenoylcysteine 7196-09-0 | (2R)-2-{3-[(2R)-2-hydroxy-3-methyl-3-[(phosphonooxy)methyl]butanamido]propanamido}-3-sulfanylpropanoic acid | C12H23N2O9PS 402.358 | |
| YMDB00205 | dTDP 491-97-4 | {[hydroxy({[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)oxolan-2-yl]methoxy})phosphoryl]oxy}phosphonic acid | C10H16N2O11P2 402.1884 | |
| YMDB00036 | 4-alpha-Methyl-5-alpha-cholest-7-en-3-beta-ol 481-25-4 | (1R,2S,5S,6S,7S,11R,15R)-2,6,15-trimethyl-14-[(2R)-6-methylheptan-2-yl]tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-9-en-5-ol | C28H48O 400.6801 |